Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionRNA helicase activity

DHX37 DDX18 DDX54

4.49e-0578183GO:0003724
GeneOntologyMolecularFunctionATP-dependent activity, acting on RNA

DHX37 DDX18 DDX54

4.84e-0580183GO:0008186
GeneOntologyMolecularFunctionperoxisome proliferator activated receptor binding

NCOR1 ASXL3

1.60e-0421182GO:0042975
GeneOntologyMolecularFunctionhelicase activity

DHX37 DDX18 DDX54

3.63e-04158183GO:0004386
GeneOntologyMolecularFunctionnuclear estrogen receptor binding

NCOR1 DDX54

1.03e-0353182GO:0030331
GeneOntologyMolecularFunctionATP-dependent activity

MYO10 DHX37 DDX18 DDX54

1.92e-03614184GO:0140657
GeneOntologyMolecularFunctioncatalytic activity, acting on RNA

DHX37 DDX18 DDX54

5.84e-03417183GO:0140098
GeneOntologyMolecularFunctionATP hydrolysis activity

DHX37 DDX18 DDX54

6.82e-03441183GO:0016887
GeneOntologyBiologicalProcessrRNA processing

KRI1 DHX37 DDX18 DDX54

3.20e-05230174GO:0006364
GeneOntologyBiologicalProcessrRNA metabolic process

KRI1 DHX37 DDX18 DDX54

6.42e-05275174GO:0016072
GeneOntologyBiologicalProcessRNA processing

CTNNBL1 HNRNPUL2 KRI1 DHX37 DDX18 INTS1 DDX54

1.08e-041500177GO:0006396
GeneOntologyBiologicalProcessribosome biogenesis

KRI1 DHX37 DDX18 DDX54

1.39e-04336174GO:0042254
GeneOntologyBiologicalProcessmaturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)

KRI1 DHX37

4.19e-0437172GO:0000462
GeneOntologyBiologicalProcessribonucleoprotein complex biogenesis

KRI1 DHX37 DDX18 DDX54

7.06e-04515174GO:0022613
GeneOntologyBiologicalProcessmaturation of SSU-rRNA

KRI1 DHX37

9.25e-0455172GO:0030490
DomainDEAD/DEAH_box_helicase_dom

DHX37 DDX18 DDX54

4.48e-0573183IPR011545
DomainDEAD

DHX37 DDX18 DDX54

4.48e-0573183PF00270
DomainHelicase_C

DHX37 DDX18 DDX54

1.40e-04107183PF00271
DomainHELICc

DHX37 DDX18 DDX54

1.40e-04107183SM00490
DomainHelicase_C

DHX37 DDX18 DDX54

1.44e-04108183IPR001650
DomainHELICASE_CTER

DHX37 DDX18 DDX54

1.48e-04109183PS51194
DomainHELICASE_ATP_BIND_1

DHX37 DDX18 DDX54

1.48e-04109183PS51192
DomainDEXDc

DHX37 DDX18 DDX54

1.48e-04109183SM00487
DomainHelicase_ATP-bd

DHX37 DDX18 DDX54

1.52e-04110183IPR014001
DomainDEAD_ATP_HELICASE

DDX18 DDX54

4.01e-0431182PS00039
DomainRNA-helicase_DEAD-box_CS

DDX18 DDX54

4.55e-0433182IPR000629
DomainRNA_helicase_DEAD_Q_motif

DDX18 DDX54

5.73e-0437182IPR014014
DomainQ_MOTIF

DDX18 DDX54

5.73e-0437182PS51195
DomainP-loop_NTPase

HNRNPUL2 MYO10 DHX37 DDX18 DDX54

9.96e-04848185IPR027417
Domain-

HNRNPUL2 DHX37 DDX18 DDX54

4.94e-037461843.40.50.300
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

CTNNBL1 HNRNPUL2 KRI1 NCOR1 DHX37 DDX18 INTS1 DDX54

1.30e-07131818830463901
Pubmed

Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus.

HNRNPUL2 DHX37 DDX18 DDX54

1.22e-0615918434578187
Pubmed

Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress.

HNRNPUL2 DHX37 DDX18 DDX54

1.22e-0615918422751105
Pubmed

Paralog Studies Augment Gene Discovery: DDX and DHX Genes.

DHX37 DDX54

1.52e-06418231256877
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

KRI1 DHX37 DDX18 INTS1 DDX54

1.61e-0565318522586326
Pubmed

Defining the membrane proteome of NK cells.

CTNNBL1 HNRNPUL2 NCOR1 DDX18 INTS1 DDX54

1.86e-05116818619946888
Pubmed

PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.

HNRNPUL2 KRI1 DHX37 DDX18 DDX54

1.93e-0567818530209976
Pubmed

Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.

HNRNPUL2 DDX18 DDX54

2.05e-0510418326167872
Pubmed

ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.

KRI1 DHX37 DDX18 DDX54

2.19e-0533018433301849
Pubmed

Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.

CTNNBL1 HNRNPUL2 KRI1 DDX18 DDX54

2.76e-0573118529298432
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

HNRNPUL2 KRI1 DHX37 DDX18 DDX54

3.31e-0575918535915203
Pubmed

The cell proliferation antigen Ki-67 organises heterochromatin.

CTNNBL1 HNRNPUL2 KRI1 DDX54

5.11e-0541018426949251
Pubmed

Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.

KRI1 NCOR1 DHX37 DDX18 DDX54

5.57e-0584718535850772
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

CTNNBL1 HNRNPUL2 KRI1 DHX37 DDX18 DDX54

5.68e-05142518630948266
Pubmed

Human transcription factor protein interaction networks.

HNRNPUL2 KRI1 NCOR1 DHX37 DDX18 DDX54

5.77e-05142918635140242
Pubmed

Mapping the Genetic Landscape of Human Cells.

CTNNBL1 DHX37 DDX18 TBC1D31

7.39e-0545118430033366
Pubmed

TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.

HNRNPUL2 MYO10 DHX37 DDX18 DDX54

9.54e-0594918536574265
Pubmed

The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.

KRI1 DHX37 DDX18 DDX54

9.63e-0548318436912080
Pubmed

In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.

CTNNBL1 KRI1 MYO10 DHX37 DDX54

1.06e-0497118533306668
Pubmed

MYC multimers shield stalled replication forks from RNA polymerase.

CTNNBL1 KRI1 DHX37 DDX18 DDX54

1.16e-0498918536424410
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

CTNNBL1 HNRNPUL2 NCOR1 DDX18 INTS1

1.30e-04101418532416067
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

CTNNBL1 HNRNPUL2 DHX37 DDX18 INTS1

1.76e-04108218538697112
Pubmed

The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.

KRI1 DHX37 DDX18

1.90e-0422018331822558
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

HNRNPUL2 KRI1 DDX18 DDX54

2.29e-0460518428977666
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

DHX37 CENPT INTS1 DDX54

2.33e-0460818436089195
Pubmed

A non-proteolytic role for ubiquitin in deadenylation of MHC-I mRNA by the RNA-binding E3-ligase MEX-3C.

HNRNPUL2 DHX37

2.36e-044418226471122
Pubmed

ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.

KRI1 NCOR1 DDX18 DDX54

2.57e-0462418433729478
Pubmed

FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3.

HNRNPUL2 KRI1 DHX37

2.70e-0424818327926873
Pubmed

Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.

KRI1 ZNF469 DDX18 DDX54

3.06e-0465318433742100
Pubmed

A screen for downstream effectors of Neurogenin2 in the embryonic neocortex.

NCOR1 SETBP1

3.30e-045218215328020
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

HNRNPUL2 KRI1 DHX37 DDX18 DDX54

3.54e-04125718536526897
Pubmed

MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer.

ASXL3 DDX18 INTS1

4.14e-0428718336180891
Pubmed

RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.

HNRNPUL2 KRI1 DDX18 DDX54

4.26e-0471318429802200
Pubmed

Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.

CTNNBL1 MYO10 DHX37 DDX18

4.49e-0472318434133714
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

CTNNBL1 HNRNPUL2 DHX37 DDX18 DDX54

4.96e-04135318529467282
InteractionH3C1 interactions

CTNNBL1 HNRNPUL2 KRI1 NCOR1 DHX37 DDX18 CENPT INTS1 DDX54

2.32e-08901189int:H3C1
InteractionTLX2 interactions

KRI1 NCOR1 DHX37 DDX18 DDX54

1.29e-07142185int:TLX2
InteractionSCARNA22 interactions

HNRNPUL2 DHX37 DDX18 DDX54

3.21e-06118184int:SCARNA22
InteractionNEIL1 interactions

CTNNBL1 KRI1 DHX37 DDX18 DDX54

3.44e-06276185int:NEIL1
InteractionNR2C2 interactions

CTNNBL1 HNRNPUL2 KRI1 NCOR1 DHX37 DDX18 INTS1 DDX54

1.26e-051403188int:NR2C2
InteractionSNRNP40 interactions

CTNNBL1 HNRNPUL2 KRI1 NCOR1 DDX18 CENPT

1.31e-05637186int:SNRNP40
InteractionZNF346 interactions

HNRNPUL2 KRI1 DHX37 DDX18 DDX54

1.56e-05377185int:ZNF346
InteractionCENPA interactions

KRI1 DHX37 DDX18 CENPT DDX54

1.56e-05377185int:CENPA
InteractionMEN1 interactions

KRI1 NCOR1 DHX37 DDX18 SETBP1 INTS1 DDX54

1.72e-051029187int:MEN1
InteractionAPOBEC3C interactions

MYO10 DHX37 DDX18 DDX54

1.98e-05187184int:APOBEC3C
InteractionSURF6 interactions

CTNNBL1 KRI1 DHX37 DDX18 DDX54

2.81e-05426185int:SURF6
InteractionSIRT7 interactions

CTNNBL1 KRI1 DHX37 DDX18 INTS1 DDX54

3.15e-05744186int:SIRT7
InteractionCDKL2 interactions

KRI1 DDX18 DDX54

3.29e-0571183int:CDKL2
InteractionRBM19 interactions

HNRNPUL2 KRI1 DHX37 DDX54

3.82e-05221184int:RBM19
InteractionSRSF5 interactions

KRI1 DHX37 DDX18 CENPT DDX54

4.69e-05474185int:SRSF5
InteractionZNF394 interactions

CTNNBL1 DDX54

5.84e-0513182int:ZNF394
InteractionFGFBP1 interactions

KRI1 DHX37 DDX18 DDX54

6.87e-05257184int:FGFBP1
InteractionMBD6 interactions

ASXL3 DDX18 INTS1

6.92e-0591183int:MBD6
InteractionMECP2 interactions

CTNNBL1 HNRNPUL2 NCOR1 DHX37 DDX18 INTS1 DDX54

7.26e-051287187int:MECP2
InteractionRPS24 interactions

CTNNBL1 KRI1 DHX37 DDX18 DDX54

7.89e-05529185int:RPS24
InteractionAURKAIP1 interactions

KRI1 DHX37 DDX18 DDX54

1.01e-04284184int:AURKAIP1
InteractionYBX2 interactions

HNRNPUL2 KRI1 DHX37 DDX18

1.08e-04289184int:YBX2
InteractionRPS10 interactions

KRI1 DHX37 ASXL3 DDX18 DDX54

1.09e-04567185int:RPS10
InteractionNOP56 interactions

KRI1 DHX37 DDX18 CENPT DDX54

1.12e-04570185int:NOP56
InteractionCDC14A interactions

KRI1 TBC1D31 DDX54

1.25e-04111183int:CDC14A
InteractionTEK interactions

HNRNPUL2 KRI1 DDX54

1.54e-04119183int:TEK
InteractionFBL interactions

HEMGN KRI1 DHX37 DDX18 DDX54

1.92e-04639185int:FBL
InteractionH1-4 interactions

KRI1 DHX37 ASXL3 DDX18 DDX54

2.17e-04656185int:H1-4
InteractionMAGEB2 interactions

KRI1 DHX37 DDX18 DDX54

2.23e-04349184int:MAGEB2
InteractionRC3H2 interactions

HNRNPUL2 KRI1 DHX37 DDX18 DDX54

2.34e-04667185int:RC3H2
InteractionRC3H1 interactions

HNRNPUL2 KRI1 DHX37 DDX18 DDX54

2.51e-04677185int:RC3H1
InteractionEIF2AK2 interactions

HNRNPUL2 KRI1 DDX18 DDX54

2.54e-04361184int:EIF2AK2
InteractionEPHB4 interactions

KRI1 DHX37 DDX54

2.81e-04146183int:EPHB4
InteractionSRPK2 interactions

CTNNBL1 HNRNPUL2 KRI1 DDX18 DDX54

3.27e-04717185int:SRPK2
InteractionDDX21 interactions

CTNNBL1 HNRNPUL2 KRI1 DDX18 DDX54

3.29e-04718185int:DDX21
InteractionFZR1 interactions

CTNNBL1 HNRNPUL2 KRI1 MYO10 DHX37 DDX54

3.87e-041172186int:FZR1
InteractionNPM1 interactions

CTNNBL1 HEMGN KRI1 DHX37 DDX18 DDX54

4.41e-041201186int:NPM1
InteractionLIN28A interactions

HNRNPUL2 KRI1 DDX18 DDX54

4.55e-04421184int:LIN28A
InteractionNIFK interactions

KRI1 DHX37 DDX18 DDX54

4.98e-04431184int:NIFK
InteractionZNF330 interactions

KRI1 DHX37 DDX18 DDX54

5.66e-04446184int:ZNF330
InteractionZBTB2 interactions

KRI1 DHX37 DDX18 DDX54

5.85e-04450184int:ZBTB2
InteractionMNDA interactions

KRI1 DDX18 DDX54

5.88e-04188183int:MNDA
InteractionSRPK3 interactions

KRI1 DDX18 DDX54

6.06e-04190183int:SRPK3
InteractionZC3H10 interactions

KRI1 DDX18 DDX54

7.04e-04200183int:ZC3H10
InteractionPPP2CA interactions

MYO10 ASXL3 SETBP1 INTS1

7.69e-04484184int:PPP2CA
InteractionBIRC3 interactions

CTNNBL1 HNRNPUL2 KRI1 DHX37 DDX18 DDX54

7.73e-041334186int:BIRC3
InteractionPOLR1G interactions

KRI1 DHX37 DDX18 DDX54

7.99e-04489184int:POLR1G
InteractionZC3H18 interactions

CTNNBL1 HNRNPUL2 KRI1 DDX18 DDX54

8.23e-04877185int:ZC3H18
InteractionMYO3B interactions

KRI1 DDX54

9.00e-0450182int:MYO3B
InteractionCLK1 interactions

NCOR1 ASXL3 CELSR3

9.16e-04219183int:CLK1
InteractionMAPRE1 interactions

HNRNPUL2 MYO10 DDX18 TBC1D31

9.63e-04514184int:MAPRE1
InteractionPURG interactions

KRI1 DHX37 DDX54

9.65e-04223183int:PURG
InteractionOASL interactions

HNRNPUL2 KRI1 DDX54

9.65e-04223183int:OASL
InteractionRPS9 interactions

CTNNBL1 KRI1 DDX18 DDX54

9.70e-04515184int:RPS9
InteractionEP300 interactions

HEMGN KRI1 NCOR1 ZNF469 DDX18 DDX54

1.00e-031401186int:EP300
InteractionZNF668 interactions

DHX37 DDX18 DDX54

1.00e-03226183int:ZNF668
InteractionMAST1 interactions

KRI1 DDX18 DDX54

1.03e-03228183int:MAST1
InteractionH1-6 interactions

KRI1 SETBP1 DDX54

1.04e-03229183int:H1-6
InteractionRPS14 interactions

HNRNPUL2 KRI1 DDX18 DDX54

1.07e-03529184int:RPS14
InteractionEED interactions

HNRNPUL2 NCOR1 DDX18 TBC1D31 INTS1 DDX54

1.18e-031445186int:EED
InteractionMAFB interactions

KRI1 DHX37 DDX18

1.28e-03246183int:MAFB
InteractionPRR3 interactions

HNRNPUL2 KRI1 DHX37

1.28e-03246183int:PRR3
InteractionSYK interactions

KRI1 DDX18 DDX54

1.36e-03251183int:SYK
InteractionHECTD1 interactions

HNRNPUL2 KRI1 DHX37 DDX18 DDX54

1.38e-03984185int:HECTD1
InteractionSNRNP70 interactions

CTNNBL1 HNRNPUL2 KRI1 DDX18 DDX54

1.38e-03984185int:SNRNP70
InteractionRBBP4 interactions

HNRNPUL2 MYO10 NCOR1 ASXL3

1.44e-03573184int:RBBP4
InteractionPSKH1 interactions

KRI1 DDX54

1.52e-0365182int:PSKH1
InteractionNPM3 interactions

KRI1 DDX18 DDX54

1.53e-03262183int:NPM3
InteractionRBM4B interactions

KRI1 DHX37 DDX54

1.53e-03262183int:RBM4B
InteractionFGF3 interactions

DDX18 DDX54

1.56e-0366182int:FGF3
InteractionUSP36 interactions

KRI1 DHX37 DDX18 DDX54

1.70e-03599184int:USP36
InteractionREST interactions

NCOR1 DDX54 CELSR3

1.74e-03274183int:REST
InteractionCBX6 interactions

KRI1 DHX37 DDX54

1.91e-03283183int:CBX6
InteractionNUP43 interactions

KRI1 NCOR1 DDX18 CENPT

1.98e-03625184int:NUP43
InteractionSIRT6 interactions

HNRNPUL2 DDX18 DDX54 CELSR3

2.02e-03628184int:SIRT6
CytobandEnsembl 112 genes in cytogenetic band chr18q12

ASXL3 SETBP1

7.59e-04104182chr18q12
CytobandEnsembl 112 genes in cytogenetic band chr12q24

DHX37 DDX54

1.13e-02415182chr12q24
GeneFamilyDEAD-box helicases

DDX18 DDX54

1.88e-044292499
ToppCellLPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ASXL3 TBC1D31 INTS1

2.91e-05151183f13a117ae26ae525da4f3e837d8f204d00dc6ee3
ToppCellsevere-HSPC|severe / disease stage, cell group and cell class

HEMGN MYOZ3 PHTF1

3.80e-05165183acd837d88ad3786c263f74651a6c0e02fa2fa2c5
ToppCellICU-NoSEP-Lymphocyte-T_NK-NK_CD56bright|ICU-NoSEP / Disease, Lineage and Cell Type

HEMGN ZNF469 TBC1D31

3.93e-05167183f4f188a8efca8cdd0ecfb857fe4538c10847eadd
ToppCellTCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-1|TCGA-Uvea / Sample_Type by Project: Shred V9

CTNNBL1 HNRNPUL2 INTS1

4.00e-05168183b427746929bb40e3d1b5f1c40d302b792d6b32a5
ToppCellsevere-HSPC|World / disease stage, cell group and cell class

HEMGN MYOZ3 PHTF1

4.08e-05169183b0421b73bfdc92f7a2762b4b670b9eae124aa702
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor

MYO10 ASXL3 SETBP1

5.51e-05187183e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCellH1299-infected-SARSCoV2|infected / Cell line, Condition and Strain

KRI1 DHX37 DDX18

6.43e-051971830fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCellSepsis-ICU-NoSEP-Lymphocyte-T/NK-NK_CD56bright|ICU-NoSEP / Disease, condition lineage and cell class

HEMGN ZNF469 TBC1D31

6.72e-05200183c2df917900872453ea17a39928e39d071a6d3339
DrugAzlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; HL60; HT_HG-U133A

MYOZ3 MYO10 PHTF1 CELSR3

1.45e-051951842727_DN
Drugbaccatin III

CTNNBL1 NCOR1

3.87e-0437182CID000065366
DrugFluticasone propionate [80474-14-2]; Down 200; 8uM; HL60; HT_HG-U133A

HNRNPUL2 MYO10 NCOR1

4.19e-041891832928_DN
Drug5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA

MYO10 DDX54 CELSR3

4.26e-04190183970_UP
Drugolmesartan medoxomil

MYOZ3 SETBP1

4.30e-0439182CID000130881
Drugretinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA

CENPT DDX54 CELSR3

4.32e-04191183991_DN
DrugHeptaminol hydrochloride [543-15-7]; Up 200; 22uM; MCF7; HT_HG-U133A

HNRNPUL2 MYO10 SETBP1

4.46e-041931831703_UP
DrugChlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; MCF7; HT_HG-U133A

HNRNPUL2 KRI1 DDX54

4.46e-041931835291_DN
DrugMethylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; MCF7; HT_HG-U133A

CTNNBL1 HNRNPUL2 DDX54

4.46e-041931834113_DN
DrugThiamphenicol [15318-45-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A

NCOR1 PHTF1 CENPT

4.46e-041931837033_DN
Drug17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A

KRI1 NCOR1 DDX54

4.52e-041941836933_DN
DrugGSK-3 Inhibitor IX; Up 200; 0.5uM; MCF7; HT_HG-U133A

CTNNBL1 NCOR1 DDX54

4.52e-041941837044_UP
DrugPrilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A

CTNNBL1 SETBP1 PHTF1

4.52e-041941834284_DN
DrugDO 897/99; Down 200; 8.2uM; HL60; HG-U133A

CTNNBL1 MYO10 NCOR1

4.52e-041941831728_DN
DrugNorfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A

HNRNPUL2 NCOR1 PHTF1

4.52e-041941837283_DN
Drug2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA

HNRNPUL2 NCOR1 CELSR3

4.52e-041941831060_UP
DrugFluspirilen [1841-19-6]; Down 200; 8.4uM; PC3; HT_HG-U133A

NCOR1 DDX54 CELSR3

4.59e-041951836662_DN
DrugAceclofenac [89796-99-6]; Down 200; 11.2uM; PC3; HT_HG-U133A

CTNNBL1 KRI1 PHTF1

4.66e-041961837269_DN
DrugLoxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A

HNRNPUL2 KRI1 CELSR3

4.66e-041961835293_DN
DrugEsculin Hydrate [531-75-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A

MYOZ3 NCOR1 CELSR3

4.66e-041961835411_DN
DrugFenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; HL60; HT_HG-U133A

MYO10 PHTF1 CELSR3

4.66e-041961832553_DN
DrugRiboflavine [83-88-5]; Up 200; 10.6uM; HL60; HG-U133A

HNRNPUL2 KRI1 CENPT

4.73e-041971831767_UP
DrugCotinine (-) [486-56-6]; Down 200; 22.6uM; HL60; HG-U133A

HNRNPUL2 PHTF1 INTS1

4.73e-041971832011_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOR1 CENPT INTS1

4.73e-041971836222_DN
DrugCarbamazepine [298-46-4]; Down 200; 17uM; MCF7; HT_HG-U133A

KRI1 MYO10 CENPT

4.73e-041971835518_DN
DrugFluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A

HNRNPUL2 MYO10 NCOR1

4.73e-041971835356_DN
DrugTHIP Hydrochloride; Up 200; 22.6uM; PC3; HT_HG-U133A

HNRNPUL2 SETBP1 DDX54

4.73e-041971837266_UP
DrugIproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A

KRI1 MYOZ3 INTS1

4.73e-041971836359_DN
Drug2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A

KRI1 NCOR1 CELSR3

4.73e-041971836941_DN
DrugCytisine (-) [485-35-8]; Down 200; 21uM; MCF7; HT_HG-U133A

HNRNPUL2 CENPT DDX54

4.73e-041971836217_DN
DrugLidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; PC3; HG-U133A

KRI1 CENPT DDX54

4.80e-041981831917_UP
DrugGanciclovir [82410-32-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A

MYOZ3 MYO10 NCOR1

4.80e-041981835389_DN
DrugEstradiol-17 beta [50-28-2]; Down 200; 14.6uM; HL60; HT_HG-U133A

HNRNPUL2 PHTF1 INTS1

4.80e-041981831299_DN
DrugMetanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A

MYO10 NCOR1 DDX54

4.80e-041981835334_DN
DrugC75; Up 200; 10uM; PC3; HT_HG-U133A

HNRNPUL2 PHTF1 CENPT

4.80e-041981836428_UP
DrugDextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; PC3; HT_HG-U133A

HNRNPUL2 DDX18 PHTF1

4.87e-041991836300_DN
DrugNifenazone [2139-47-1]; Down 200; 13uM; HL60; HG-U133A

HNRNPUL2 NCOR1 CENPT

4.87e-041991831439_DN
Drug3-hydroxy-(D/L)-kynurenine; Down 200; 9.2uM; MCF7; HT_HG-U133A_EA

CTNNBL1 HNRNPUL2 DDX54

4.87e-041991831109_DN
DrugBumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A

KRI1 MYO10 CELSR3

4.87e-041991835542_DN
DrugAH6809; Up 200; 1uM; PC3; HT_HG-U133A

CTNNBL1 CENPT DDX54

4.87e-041991837075_UP
Diseaseinositol measurement

MYO10 SETBP1

2.83e-0514172EFO_0010504
Diseaseresponse to antidepressant

MYO10 ASXL3 DDX54

1.33e-04176173GO_0036276
Diseasebasophil percentage of leukocytes

KRI1 ZNF469 PHTF1

3.44e-04243173EFO_0007992
DiseaseNeurodevelopmental Disorders

ASXL3 SETBP1

1.30e-0393172C1535926
DiseaseWeight Gain

MYO10 SETBP1

1.56e-03102172C0043094
DiseaseMalignant neoplasm of liver

NCOR1 DDX54

2.98e-03142172C0345904
DiseaseLiver neoplasms

NCOR1 DDX54

2.98e-03142172C0023903
Diseaseunipolar depression, bipolar disorder

ASXL3 SETBP1

3.59e-03156172EFO_0003761, MONDO_0004985
Diseasehair colour measurement

CTNNBL1 ZNF469 SETBP1

4.93e-03615173EFO_0007822
Diseasebody weight

NCOR1 ASXL3 SETBP1 TBC1D31

5.06e-031261174EFO_0004338
Diseaselymphocyte count

NCOR1 ZNF469 DDX18 PHTF1

8.55e-031464174EFO_0004587
Diseasenon-melanoma skin carcinoma

ZNF469 PHTF1

1.00e-02265172EFO_0009260

Protein segments in the cluster

PeptideGeneStartEntry
RNLRGQQRTRLLNKF

CTNNBL1

416

Q8WYA6
ALKQALRQQQKRRNG

ASXL3

156

Q9C0F0
RQRQQKQRQLLGRLQ

INTS1

941

Q8N201
KQRRRAQKLHFLQRG

DDX54

831

Q8TDD1
RNKRNRQNRSRGQGY

HNRNPUL2

646

Q1KMD3
QKQLRGQIARRVYRQ

MYO10

796

Q9HD67
FRQLGRQRRKQQGPK

KRI1

686

Q8N9T8
RNLKLRQRNLKFQGA

DDX18

16

Q9NVP1
QRTGKGNRRGRKRQQ

HEMGN

66

Q9BXL5
GRRKQRLRLSVFQQG

CENPT

151

Q96BT3
GRAQRQRKGILKNRL

CELSR3

3001

Q9NYQ7
MGKLRRRYNIKGRQQ

DHX37

1

Q8IY37
GQNLIKKVRNLRQRL

TBC1D31

1036

Q96DN5
VRRNYGKRRGRNQQI

NCOR1

491

O75376
NNGNRRRRKLRKTVN

PHTF1

156

Q9UMS5
QGRQQRRGKQLKLFR

ZNF469

941

Q96JG9
GNNFVKKRRGRPRKQ

SETBP1

1446

Q9Y6X0
NRGSLLFQKRQRRVQ

MYOZ3

46

Q8TDC0